659 related articles for article (PubMed ID: 12525232)
61. Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.
Blake GJ; Ridker PM; Kuntz KM
Am J Med; 2003 Apr; 114(6):485-94. PubMed ID: 12727581
[TBL] [Abstract][Full Text] [Related]
62. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
[TBL] [Abstract][Full Text] [Related]
63. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
64. Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes.
Pan X; Dvortsin E; Baldwin DR; Groen HJM; Ramaker D; Ryan J; Berge HT; Velikanova R; Oudkerk M; Postma MJ
J Med Econ; 2024; 27(1):27-38. PubMed ID: 38050691
[TBL] [Abstract][Full Text] [Related]
65. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.
JAMA; 1998 Nov; 280(20):1757-63. PubMed ID: 9842951
[TBL] [Abstract][Full Text] [Related]
66. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.
Goldie SJ; Kuntz KM; Weinstein MC; Freedberg KA; Welton ML; Palefsky JM
JAMA; 1999 May; 281(19):1822-9. PubMed ID: 10340370
[TBL] [Abstract][Full Text] [Related]
67. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
68. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
69. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
[TBL] [Abstract][Full Text] [Related]
70. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis.
Chirikos TN; Hazelton T; Tockman M; Clark R
Chest; 2002 May; 121(5):1507-14. PubMed ID: 12006436
[TBL] [Abstract][Full Text] [Related]
71. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
Black C; Bagust A; Boland A; Walker S; McLeod C; De Verteuil R; Ayres J; Bain L; Thomas S; Godden D; Waugh N
Health Technol Assess; 2006 Jan; 10(3):iii-iv, ix-x, 1-90. PubMed ID: 16409881
[TBL] [Abstract][Full Text] [Related]
72. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.
Cadham CJ; Cao P; Jayasekera J; Taylor KL; Levy DT; Jeon J; Elkin EB; Foley KL; Joseph A; Kong CY; Minnix JA; Rigotti NA; Toll BA; Zeliadt SB; Meza R; Mandelblatt J;
J Natl Cancer Inst; 2021 Aug; 113(8):1065-1073. PubMed ID: 33484569
[TBL] [Abstract][Full Text] [Related]
73. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
Caverly TJ; Cao P; Hayward RA; Meza R
Ann Intern Med; 2018 Jul; 169(1):1-9. PubMed ID: 29809244
[TBL] [Abstract][Full Text] [Related]
74. Retrospective cost-effectiveness analysis of screening mammography.
Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
[TBL] [Abstract][Full Text] [Related]
75. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
[TBL] [Abstract][Full Text] [Related]
76. Economic decision analysis model of screening for lung cancer.
Marshall D; Simpson KN; Earle CC; Chu CW
Eur J Cancer; 2001 Sep; 37(14):1759-67. PubMed ID: 11549429
[TBL] [Abstract][Full Text] [Related]
77. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
[TBL] [Abstract][Full Text] [Related]
78. Multi-slice/helical computed tomography for lung cancer screening.
Banerjee S
Issues Emerg Health Technol; 2003 Jun; (48):1-4. PubMed ID: 12812212
[TBL] [Abstract][Full Text] [Related]
79. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
80. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
Atsou K; Chouaid C; Hejblum G
PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
